Catinazzo Thomas — SEC Form 4 filings
SEC reporting owner CIK 1818261. 26 Form 4 filings on record with FilingPulse; latest filed 2026-09-09.
Transaction summary — filings shown
Covers all 26 filings on record, filed 2024-01-18 to 2026-09-09. Counts and totals are arithmetic on values as filed — descriptive data, not a recommendation.
- Open-market purchases (code P, non-derivative): none reported.
- Open-market sales (code S, non-derivative): 42 legs across 23 filings — 482,572 shares, $5,899,164 total (shares × price as filed).
- Other reported legs (grants, option exercises, tax withholding, gifts, derivative-security transactions, …): 12.
- Largest priced transaction: sale of 61,563 shares @ $16.97 ($1,044,724) in Relay Therapeutics, Inc., filed 2026-06-24.
By issuer — same filings
Open-market purchase/sale legs on non-derivative securities, grouped by issuer. Role is as filed on the newest filing for that issuer. Dollar totals cover priced legs only (shares × price as filed). Ordered by priced transaction value, largest first.
| Issuer | Role (as filed) | Filings | Purchases (P) | Sales (S) | Other legs |
|---|---|---|---|---|---|
| Relay Therapeutics, Inc. (RLAY) | Chief Financial Officer | 26 | — | 42 legs · 482,572 sh · $5,899,164 | 12 |
Form 4 filings — Catinazzo Thomas
| Filed | Form | Issuer | Reported transactions | Source |
|---|---|---|---|---|
| 2026-09-09 | 4 | Relay Therapeutics, Inc. (RLAY) | Sale (S): 17,717 @ $18.94 | EDGAR |
| 2026-08-18 | 4 | Relay Therapeutics, Inc. (RLAY) | Sale (S): 17,717 @ $19.74 | EDGAR |
| 2026-07-30 | 4 | Relay Therapeutics, Inc. (RLAY) | Sale (S): 1,459 @ $18.61 | EDGAR |
| 2026-07-08 | 4 | Relay Therapeutics, Inc. (RLAY) | Sale (S): 17,717 @ $18.69 | EDGAR |
| 2026-06-24 | 4 | Relay Therapeutics, Inc. (RLAY) | Sale (S): 17,717 @ $17.01 · Option exercise (M): 56,323 @ $5.04 · Sale (S): 56,323 @ $16.97 · Option exercise (M): 61,563 @ $5.22 · Sale (S): 61,563 @ $16.97 · Option exercise (M): 51,560 @ $4.45 · +4 more | EDGAR |
| 2026-05-14 | 4 | Relay Therapeutics, Inc. (RLAY) | Sale (S): 17,717 @ $12.86 | EDGAR |
| 2026-04-30 | 4 | Relay Therapeutics, Inc. (RLAY) | Sale (S): 972 @ $14.79 | EDGAR |
| 2026-04-09 | 4 | Relay Therapeutics, Inc. (RLAY) | Sale (S): 17,717 @ $13.01 · Option exercise (M): 1,800 @ $5.22 · Sale (S): 1,800 @ $15 · Option exercise (M): 1,800 (derivative) @ $0 | EDGAR |
| 2026-03-11 | 4 | Relay Therapeutics, Inc. (RLAY) | Sale (S): 17,717 @ $10.06 | EDGAR |
| 2026-01-29 | 4 | Relay Therapeutics, Inc. (RLAY) | Sale (S): 13,820 @ $7.62 · Sale (S): 1,695 @ $8.45 | EDGAR |
| 2026-01-15 | 4 | Relay Therapeutics, Inc. (RLAY) | Grant/award (A): 400,000 (derivative) @ $0 | EDGAR |
| 2025-10-30 | 4 | Relay Therapeutics, Inc. (RLAY) | Sale (S): 21,664 @ $7.29 | EDGAR |
| 2025-07-30 | 4 | Relay Therapeutics, Inc. (RLAY) | Sale (S): 1,701 @ $3.74 · Sale (S): 18,380 @ $3.68 | EDGAR |
| 2025-04-30 | 4 | Relay Therapeutics, Inc. (RLAY) | Sale (S): 1,709 @ $3.17 · Sale (S): 981 @ $3.17 · Sale (S): 3,558 @ $3.23 · Sale (S): 12,943 @ $3 | EDGAR |
| 2025-03-31 | 4 | Relay Therapeutics, Inc. (RLAY) | Sale (S): 298 @ $2.84 · Sale (S): 4,566 @ $2.84 | EDGAR |
| 2025-01-30 | 4 | Relay Therapeutics, Inc. (RLAY) | Sale (S): 33,753 @ $4.63 · Sale (S): 2,283 @ $4.63 · Grant/award (A): 139,141 @ $0 · Sale (S): 2,109 @ $4.55 · Sale (S): 20,791 @ $4.42 | EDGAR |
| 2025-01-14 | 4 | Relay Therapeutics, Inc. (RLAY) | Grant/award (A): 275,000 (derivative) @ $0 | EDGAR |
| 2024-12-31 | 4 | Relay Therapeutics, Inc. (RLAY) | Sale (S): 299 @ $4.38 · Sale (S): 4,566 @ $4.42 | EDGAR |
| 2024-10-30 | 4 | Relay Therapeutics, Inc. (RLAY) | Sale (S): 1,697 @ $6.06 · Sale (S): 5,105 @ $6.06 · Sale (S): 2,300 @ $5.95 | EDGAR |
| 2024-10-01 | 4 | Relay Therapeutics, Inc. (RLAY) | Sale (S): 295 @ $7.51 · Sale (S): 6,162 @ $7.46 | EDGAR |
| 2024-07-31 | 4 | Relay Therapeutics, Inc. (RLAY) | Sale (S): 1,702 @ $8.85 · Sale (S): 9,078 @ $8.51 | EDGAR |
| 2024-07-01 | 4 | Relay Therapeutics, Inc. (RLAY) | Sale (S): 295 @ $6.26 · Sale (S): 9,078 @ $6.24 | EDGAR |
| 2024-04-29 | 4 | Relay Therapeutics, Inc. (RLAY) | Sale (S): 1,695 @ $6.38 | EDGAR |
| 2024-03-29 | 4 | Relay Therapeutics, Inc. (RLAY) | Sale (S): 348 @ $7.70 | EDGAR |
| 2024-01-31 | 4 | Relay Therapeutics, Inc. (RLAY) | Sale (S): 2,005 @ $9.64 | EDGAR |
| 2024-01-18 | 4 | Relay Therapeutics, Inc. (RLAY) | Grant/award (A): 200,000 @ $0 | EDGAR |
FilingPulse's Form 4 archive currently extends back to 2024-01-11 and is expanding backward through EDGAR history — earlier filings by this insider may not be indexed yet. Names and roles are shown as filed.
Need this as JSON?
GET https://api.filingpulse.io/v1/insider-trades?owner_cik=1818261 returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new filings to you in seconds. API docs →